Bio-Path Holdings Inc Stock Nasdaq
Equities
US09057N1028
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.66M 4.98M |
---|---|---|---|---|---|
Net income 2024 * | -13M -17.69M | Net income 2025 * | -14M -19.05M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.22
x | P/E ratio 2025 * |
-0.27
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.41% |
Latest transcript on Bio-Path Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 07-05-09 | |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
Douglas Morris
FOU | Founder | 68 | 07-05-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Morris
FOU | Founder | 68 | 07-05-09 |
Heath Cleaver
BRD | Director/Board Member | 51 | 14-02-10 |
Peter Nielsen
CEO | Chief Executive Officer | 75 | 07-05-09 |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |